title: Changes in diastolic cardiac function in developing and stable perinephritic hypertension in conscious dogs.
abstract: The effects of developing perinephritic hypertension (2-3 weeks) and a more stable period of perinephritic hypertension (approximately 14 weeks) were examined on indexes of left ventricular (LV) diastolic function in conscious, chronically instrumented dogs. The complete period of diastole was studied using indexes of isovolumic relaxation (tau), early filling (LV +dD/dt), and stiffness (myocardial stiffness and chamber stress/diameter ratio). During developing hypertension, increased LV end-diastolic pressure, LV end-diastolic stress, peak filling rate, myocardial stiffness, and the stress/diameter ratio increased (p less than 0.05); the time constant tau was not changed. These changes were associated with preserved baseline levels of coronary blood flow (radioactive microspheres) but an impaired coronary vasodilator response to adenosine. Acute administration of phenylephrine in the normotensive dogs caused increases in systolic and diastolic stress and resulted in increases in myocardial stiffness and in the stress/diameter ratio similar to values observed in developing hypertension. During stable hypertension, LV end-diastolic stress, peak filling rate, and both parameters of late-diastolic function (myocardial stiffness and stress/diameter ratio) returned toward control values, but the isovolumic relaxation time constant was increased. Quantitative histological evaluation revealed no increase in stainable connective tissue in dogs with stable hypertension compared with control dogs, and hydroxyproline concentration was not increased in the subendomyocardium, midmyocardium, or subepimyocardium of the dogs with chronic perinephritic hypertension. Thus, in developing hypertension, major alterations in diastolic function were observed that were not structurally related, since these changes 1) could be induced in normal dogs by increasing preload and afterload acutely with phenylephrine and 2) were improved during the ensuing stable period of hypertension.
authors.affiliation: Department of Medicine, Harvard Medical School, Boston, MA.
authors.forename: R J
authors.initials: RJ
authors.lastname: Gelpi
authors.forename: A
authors.initials: A
authors.lastname: Pasipoularides
authors.forename: A S
authors.initials: AS
authors.lastname: Lader
authors.forename: T A
authors.initials: TA
authors.lastname: Patrick
authors.forename: N
authors.initials: N
authors.lastname: Chase
authors.forename: L
authors.initials: L
authors.lastname: Hittinger
authors.forename: R P
authors.initials: RP
authors.lastname: Shannon
authors.forename: S P
authors.initials: SP
authors.lastname: Bishop
authors.forename: S F
authors.initials: SF
authors.lastname: Vatner
mesh_terms: D000241:Adenosine / Q000494:pharmacology; D000818:Animals; D003238:Connective Tissue / Q000473:pathology; D003326:Coronary Circulation / Q000187:drug effects; D003971:Diastole; D004285:Dogs; D005260:Female; D006321:Heart / Q000503:physiopathology*; D006973:Hypertension / Q000209:etiology / Q000473:pathology / Q000503:physiopathology*; D008297:Male; D009206:Myocardium / Q000473:pathology; D009929:Organ Size; D010501:Perinephritis / Q000150:complications / Q000503:physiopathology*; D010656:Phenylephrine / Q000494:pharmacology; D012016:Reference Values; D013599:Systole; D016277:Ventricular Function, Left
chemical_list: D010656:Phenylephrine; D000241:Adenosine